|
Mr. Emmens has been a member of our Board of Directors since 2004. Mr. Emmens is the Chief Executive Officer Chairman of the Executive Committee and a member of the Board of Directors of Shire Pharmaceuticals Group plc. Before joining Shire in 2003 Mr. Emmens served as president of Merck KGaA's global prescription pharmaceuticals business in Darmstadt Germany. In 1999 he joined Merck KGaA and established EMD Pharmaceuticals its United States prescription pharmaceutical business. Mr. Emmens held the position of President and Chief Executive Officer at EMD Pharmaceuticals from 1999 to 2001. Prior to this Mr. Emmens held various positions including Chief Executive Officer at Astra Merck Inc. as well as several positions at Merck & Co. Inc. Mr. Emmens also currently serves as a director of Incyte Corporation. Mr. Emmens received a B.S. degree in business management from Farleigh Dickinson University.
Member of the Corporate Governance and Nominating Committee
Member of the Science and Technology Committee
Chair of the Commercial Strategy Committee | 